Literature DB >> 21892768

Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.

Renhua Fan1, Pingsheng Chen, Di Zhao, Jing Long Tong, Jing Li, Feng Liu.   

Abstract

Aberrant Notch signaling and Ras pathway had been highlighted a potential role for in human cancers. Yet, relatively little was known about the roles of wild type Notch signaling and Ras in human hepatocarcinogenesis. The aim of this study was to investigate the roles of Ras-Notch signaling cooperation in hepatic cells transformation and proliferation. Hepatocellular carcinoma specimens from 25 patients were analyzed for Notch-1, Ras and Late Simian Virus 40 Factor (LSF) expression using immunohistochemistry. Results showed that Notch-1(76%, 19/25, P < 0.0001), Ras (40%, 10/25, P < 0.01) and LSF (84%, 21/25, P < 0.0001) were significantly up-regulated in hepatocellular carcinoma compared with non-cancer samples. The correlations between the expression and the biological effects of Notch1 and Ras were analyzed by genetic and pharmacological methods. Constitutively active Notch1 alone failed to transform immortalized L02 cells in vivo, it synergized with the Ras pathway to promote hepatic cells transformation. However, their cooperation increased the levels of LSF mRNA and protein, which stimulates L02 cells proliferation. These results exhibited highly aggressive progression, suggesting that Notch-Ras cooperation maybe lead to poor prognosis. Thus, combining the inhibition of the two pathways provided an attractive avenue for therapeutic intervention to overcome this advanced disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892768     DOI: 10.1007/s10735-011-9353-3

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  46 in total

1.  Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.

Authors:  Huw D Lewis; Matthew Leveridge; Peter R Strack; Christine D Haldon; Jennifer O'neil; Hellen Kim; Andrew Madin; Joanne C Hannam; A Thomas Look; Nancy Kohl; Giulio Draetta; Timothy Harrison; Julie A Kerby; Mark S Shearman; Dirk Beher
Journal:  Chem Biol       Date:  2007-02

2.  The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions.

Authors:  B Daniel; A Rangarajan; G Mukherjee; E Vallikad; S Krishna
Journal:  J Gen Virol       Date:  1997-05       Impact factor: 3.891

3.  Activation of Notch signaling in tumorigenesis of experimental pancreatic cancer induced by dimethylbenzanthracene in mice.

Authors:  Kenji Kimura; Kennichi Satoh; Atsushi Kanno; Shin Hamada; Morihisa Hirota; Mareyuki Endoh; Atsushi Masamune; Tooru Shimosegawa
Journal:  Cancer Sci       Date:  2007-02       Impact factor: 6.716

4.  Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.

Authors:  Franziska Jundt; Ioannis Anagnostopoulos; Reinhold Förster; Stephan Mathas; Harald Stein; Bernd Dörken
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

5.  Notch1 functions as a tumor suppressor in mouse skin.

Authors:  Michael Nicolas; Anita Wolfer; Kenneth Raj; J Alain Kummer; Pleasantine Mill; Mascha van Noort; Chi-chung Hui; Hans Clevers; G Paolo Dotto; Freddy Radtke
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

6.  Alterations of the Notch pathway in lung cancer.

Authors:  Britta Westhoff; Ivan N Colaluca; Giovanni D'Ario; Maddalena Donzelli; Daniela Tosoni; Sara Volorio; Giuseppe Pelosi; Lorenzo Spaggiari; Giovanni Mazzarol; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

7.  Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model.

Authors:  Shigeo Masuda; Keiki Kumano; Takahiro Suzuki; Taisuke Tomita; Takeshi Iwatsubo; Hideaki Natsugari; Arinobu Tojo; Makoto Shibutani; Kunitoshi Mitsumori; Yutaka Hanazono; Seishi Ogawa; Mineo Kurokawa; Shigeru Chiba
Journal:  Cancer Sci       Date:  2009-08-27       Impact factor: 6.716

8.  Mammalian transcription factor LSF is a target of ERK signaling.

Authors:  Zrinka Pagon; Janet Volker; Geoffrey M Cooper; Ulla Hansen
Journal:  J Cell Biochem       Date:  2003-07-01       Impact factor: 4.429

9.  Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.

Authors:  Sanne Weijzen; Paola Rizzo; Mike Braid; Radhika Vaishnav; Suzanne M Jonkheer; Andrei Zlobin; Barbara A Osborne; Sridevi Gottipati; Jon C Aster; William C Hahn; Michael Rudolf; Kalliopi Siziopikou; W Martin Kast; Lucio Miele
Journal:  Nat Med       Date:  2002-08-19       Impact factor: 53.440

10.  Transcription factors LSF and E2Fs: tandem cyclists driving G0 to S?

Authors:  Ulla Hansen; Laura Owens; Utsav H Saxena
Journal:  Cell Cycle       Date:  2009-07-21       Impact factor: 4.534

View more
  4 in total

1.  Activation of signal transduction pathways during hepatic oncogenesis.

Authors:  Waihong Chung; Miran Kim; Suzanne de la Monte; Lisa Longato; Rolf Carlson; Betty L Slagle; Xiaoqun Dong; Jack R Wands
Journal:  Cancer Lett       Date:  2015-10-01       Impact factor: 8.679

2.  AhR expression is increased in hepatocellular carcinoma.

Authors:  Ziyu Liu; Xing'an Wu; Fanglin Zhang; Lurong Han; Guoqiang Bao; Xianli He; Zhikai Xu
Journal:  J Mol Histol       Date:  2013-04-02       Impact factor: 2.611

3.  Expression of TSG101 protein and LSF transcription factor in HPV-positive cervical cancer cells.

Authors:  Justyna K Broniarczyk; Alicja Warowicka; Anna Kwaśniewska; Maria Wohuń-Cholewa; Wojciech Kwaśniewski; Anna Goździcka-Józefiak
Journal:  Oncol Lett       Date:  2014-03-11       Impact factor: 2.967

4.  OncomiRdbB: a comprehensive database of microRNAs and their targets in breast cancer.

Authors:  Rimpi Khurana; Vinod Kumar Verma; Abdul Rawoof; Shrish Tiwari; Rekha A Nair; Ganesh Mahidhara; Mohammed M Idris; Alan R Clarke; Lekha Dinesh Kumar
Journal:  BMC Bioinformatics       Date:  2014-01-15       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.